239
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Investigation of the Effect of Milrinone on Renal Damage in an Experimental Non-Heart Beating Donor Model

, MD, , , , , , , & show all
Pages 402-411 | Received 22 May 2017, Accepted 13 Jun 2017, Published online: 14 Jul 2017

REFERENCES

  • Yıldız I, Koca YS, Sabuncuoglu MZ. Urgent organ retrieval from non-heart-beating donor with declared brain death: harvest at arrest. Chirurgia (Bucur). 2017;112:130–135.
  • Nishikido M, Noguchi M, Koga S, et al. Kidney transplantation from non-heart-beating donors: analysis of organ procurement and outcome. Transplant Proc. 2004;36:1888–90.
  • Teraoka S, Nomoto K, Kikuchi K, et al. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report. Clin Transpl. 2004:91–102.
  • Gentil MA, Castro de la Nuez P, Gonzalez-Corvillo C, et al. Non-heart-beating donor kidney transplantation survival is similar to donation after brain death: comparative study with controls in a regional program. Transplant Proc. 2016;48:2867–2870.
  • Tanabe K, Oshima T, Tokumoto T, et al. Long-term renal function in on-heart-beating donor kidney transplantation: a single-center experience. Transplantation. 1998;66:1708–13.
  • Salgado A, Boveda JL, Monasterio J, et al. Inflammatory mediators and their influence on haemostasis. Haemostasis. 1994;24:132–8.
  • Bombeli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost. 1997;77:408–23.
  • Donnahoo KK, Shames BD, Harken AH. Review article: the role of tumor necrosis factor in renal ischemia reperfusion injury. J Urol. 1999;162:196–203.
  • Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol. 2006;147:252–257.
  • Jung HS, Joo JD, Kim DW, et al. Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice. Korean J Anesthesiol. 2014;66:136–42.
  • Nishiki T, Kitada H, Okabe Y, et al. Effect of milrinone on ischemia-reperfusion injury in the rat kidney. Transplant Proc. 2011;43:1489–94.
  • Satoh K, Kume M, Abe Y, et al. Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment. J Surg Res. 2009;155:32–39.
  • Huang MH, Poh KK, Tan HC, Welt FG, Lui CY. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition. Int J Cardiol. 2016;214:374–80.
  • Karımfar HM, Gholizadeh S, Hajrasouliha AP, et al. Low dose morphine enhances morphine antinociception effects in the animals pretreated with selective and non-selective phosphodiestrase inhibitors. IJPS. 2009;5:73–81.
  • Dietrichs ES, Kondratiev T, Tveita T. Milrinone ameliorates cardiac mechanical dysfunction after hypothermia in an intact rat model. Cryobiology. 2014;69:361–6.
  • Toyoda T, Tosaka S, Tosaka R, et al. Milrinone-induced postconditioning reduces hepatic ischemia-reperfusion injury in rats: the roles of phosphatidylinositol 3-kinase and nitric oxide. J Surg Res. 2014;186:446–51.
  • Kume M, Banafsche R, Yamamoto Y, et al. Dynamic change of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, Milrinone. J Surg Res. 2006;136:209–218.
  • Baruch L, Patacsil P, Hameed A, Pina I, Loh E. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J. 2001;141:266–73.
  • Jafari A, Baghaei A, Solgi R, et al. An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats. Food Chem Toxicol. 2015;80:182–92.
  • Desjardins S, Cauchy MJ. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure. Arch Int Pharmacodyn Ther. 1989;301:182–99.
  • Hu QH, Luo FY, Luo WJ, Wang L. Ischemic postconditioning reduces ischemic reperfusion injury of non-heart-beating donor grafts in a rat lung transplant. Exp Clin Transplant. 2013;11:44–9.
  • Niu X, Huang WH, De Boer B, Delriviere L, Mou LJ, Jeffrey GP. Iron-induced oxidative rat liver injury after non-heart-beating warm ischemia is mediated by tumor necrosis factor α and prevented by deferoxamine. Liver Transpl. 2014;20:904–11.
  • Dutkowski P, Furrer K, Tian Y, Graf R, Clavien PA. Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg. 2006;244(6):968–76.
  • Kashiwadate T, Miyagi S, Hara Y, Akamatsu Y, et al. Recombinant human soluble thrombomodulin (ART-123) prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donors. Transplant Proc. 2012;44:369–72.
  • Akalın B, Yılmaz Z, Artıs T. The effect of met-rantes on liver damage in a controlled experimental non-heart beating donor model. Erciyes Med J. 2012;34:69–72.
  • Cetin MM, Yılmaz Z, Artıs T, Deniz K, Saraymen R. The effect of edaravone on liver damage in controlled experimental non-heart-beating donor model. Er. Med J. 2012;34:127–31.
  • American Veterinary Medical Association AVMA Guidelines for the Euthanasia of Animals:2013Edition. Available at https://www.avma.org/KB/Policies/Documents/euthanasia.pdf
  • Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM. Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transpl. 2005;11:1379–88.
  • Laskowski IA, Pratschke J, Wilhelm MM, et al. Early and late injury to renal transplants from non-heart-beating donors. Transplantation. 2002;73:1468–73.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
  • Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86:271–8.
  • McCord JM, Fridovich I. Superoxide dysmutase. An enzymic function for erythrocuprein. J Biol Chem. 1969;244:6049–55.
  • Luck H. Catalase. In: Methods of Enzymatic Analysis 2nd ed. Begmeyer HU Ed. New York: Academic Press/Verlag Chemie; 1963:885–94.
  • Lawrence RA, Burk RF. GSH-Px activity in rat liver. Biochem Biophys Res Commun. 1976;71:952–58.
  • Levy JH, Ramsay J, Bailey JM. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothorac Anesth. 1990;4:7–11.
  • Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190:255–266.
  • Mizutani A, Murakami K, Okajima K. Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock. 2005;24:281.
  • Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappa B-dependent increase in lymphocyte adhesion. Hepatology. 2007;45:465–474.
  • Lanfear DE, Hasan R, Gupta RC, et al. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. J Transl Med. 2009;7:67.
  • Usta E, Mustafi M, Scheule AM, Ziemer G. Suppressing apoptosis with milrinone simulating extracorporeal circulation: a pilot study. Thorac Cardiovasc Surg. 2010;58:285–90.
  • Huang MH, Wu Y, Nguyen V, et al. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovasc Drugs Ther. 2011;25:223–32.
  • Schumer M, Colombel MC, Sawczuk IS, et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol. 1992;140:831.
  • Chiang-Ting C, Tzu-Ching C, Ching-Yi T, Song-Kuen S, Ming-Kuen L. Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant. 2005;5:1194–1203.
  • Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, Martin SJ. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA. 2008;105:12815–12819.
  • Xie J, Guo Q. Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. J Am Soc Nephrol. 2006;17:3336–46.
  • Anaya-Prado R, Toledo-Pereyra LH. The molecular events underlying ischemia/reperfusion injury. Transplant Proc. 2002;34:2518–9.
  • Bircan B, Çakır M, Kırbağ S, Gül HF. Effect of apelin hormone on renal ischemia/reperfusion induced oxidative damage in rats. Ren Fail. 2016;38:1122–8.
  • Nakagawa T, Yokozawa T, Satoh A, Kim HY. Attenuation of renal ischemia-reperfusion injury by proanthocyanidin-rich extract from grape seeds. J Nutr Sci Vitaminol (Tokyo). 2005;51:283–6.
  • Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156–1164.
  • Cakir M, Polat A, Tekin S, et al. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats. Ren Fail. 2015;37:704–708.
  • Cong G, Cui L, Zang M, Hao L. Attenuation of renal ischemia/reperfusion injury by a polysaccharide from the roots of Dipsacus asperoides. Int J Biol Macromol. 2013;56:14–9.
  • Cakir M, Duzova H, Baysal I, et al. The effect of hypericum perforatum on kidney ischemia/reperfusion damage. Ren Fail. 2017;39:385–391.
  • Gaweł S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek. 2004;57:453–5.
  • Bozlu M, Coskun B, Cayan S, et al. Inhibition of poly (adenosine diphosphata-ribose) polymerase decreases long-term histologic damage intesticular ischemia-reperfusion injury. Urology. 2004;63:791–5.
  • Bektas S, Karakaya K, Can M, et al. The effects of tadalafil and pentoxifylline on apoptosis and nitric oxide synthase in liver ischemia/reperfusion injury. Kaohsiung J Med Sci. 2016;32:339–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.